Stuart Bondurant

This profile gathers the share dealings of Stuart Bondurant across 2 companies, led by Pharmaceutical Product Development Inc and Furiex Pharmaceuticals, Inc. In total, 10 filings cover trades dated from 3 January 2006 to 5 December 2011.

Purchases make up the whole of the open-market record (2 purchases, €73k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 7 share grants. In 2011 alone, the filings show 2 purchases and no sales.

The latest filing, published on 7 December 2011, reports an open-market purchase of €37k in Furiex Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.